EcoDrugPlus

C-C Motif Chemokine Receptor 5

Ensembl ID : ENSBBBG00000003120
Gene Symbol: CCR5
3 Cross references
152 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSBBBG00000003058
Gene Symbol: CCR9
3 Cross references
265 Possible Orthologues:

C-X-C Motif Chemokine Ligand 8

Ensembl ID : ENSBBBG00000017205
Gene Symbol: CXCL8
3 Cross references
139 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSBBBG00000012508
Gene Symbol: CXCR4
3 Cross references
218 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSBBBG00000024730
Gene Symbol: CFTR
3 Cross references
217 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSBBBG00000003484
Gene Symbol: DNMT1
3 Cross references
212 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSBBBG00000003577
Gene Symbol: TOP1
3 Cross references
273 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSBBBG00000024833
Gene Symbol: TOP2A
3 Cross references
206 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSBBBG00000011838
Gene Symbol: TOP2B
3 Cross references
210 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSBBBG00000014473
Gene Symbol: EML4
3 Cross references
214 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSBBBG00000015296
Gene Symbol: EPHA3
3 Cross references
216 Possible Orthologues:

Eph Receptor B4

Ensembl ID : ENSBBBG00000022706
Gene Symbol: EPHB4
3 Cross references
168 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).